nerolidol has been researched along with Liver Dysfunction in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Ali, J; Haque, MM; Haque, SE; Iqubal, A; Najmi, AK; Syed, MA | 1 |
1 other study(ies) available for nerolidol and Liver Dysfunction
Article | Year |
---|---|
Nerolidol protects the liver against cyclophosphamide-induced hepatic inflammation, apoptosis, and fibrosis via modulation of Nrf2, NF-κB p65, and caspase-3 signaling molecules in Swiss albino mice.
Topics: Animals; Apoptosis; Caspase 3; Cyclophosphamide; Disease Models, Animal; Fibrosis; Inflammation; Liver; Liver Diseases; Male; Mice; NF-E2-Related Factor 2; Sesquiterpenes; Signal Transduction; Transcription Factor RelA | 2020 |